SightfileU.S. market data from official filings

Pasithea Therapeutics Corp (KTTA)

Name: Pasithea Therapeutics Corp (KTTA) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001841330 · EDGAR filings · Updated 2026-07-01

Pasithea Therapeutics Corp (KTTA) has reported institutional ownership of 51.4%, with 21 institutional managers holding positions valued at $9.52M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

51.4%

Institutional managers

Reported 13F value

$9.52M

Insider activity

6 trans.

$149.2K net buying

Data flags

2 active

from SEC filings

Latest updates

2026-07-01 — SCHEDULE 13G/A filed
2026-06-23 — SCHEDULE 13G filed
2026-06-22 — Insider transaction reported (Form 4)
2026-05-15 — Quarterly report (10-Q) filed
2026-05-15 — SCHEDULE 13G/A filed
2026-05-05 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Pasithea Therapeutics Corp has 21 institutional holders and institutional ownership of 51.4%.

Insider activity

Insiders reported 6 transactions (3 buys, 1 sells) across 5 reporting insiders, with a net reported value of $149.2K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2024-03-29) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-02-20 (recurring since 2023-01-24) — source filing. The authoritative details are those stated in the filing itself.

Related companies

OKYO PHARMA LTD (OKYO) · SKYE BIOSCIENCE INC (SKYE) · BeyondSpring Inc (BYSI) · Boundless Bio Inc (BOLD) · CYTOSORBENTS CORP (CTSO) · ONEMEDNET CORP (ONMD)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-01.